ZONEGRAN (zonisamide) Indications
ZONEGRAN is approved as adjunctive therapy for the treatment of partial seizures in adults with epilepsy. [1]
Approved Indication Criteria
- Partial (focal) seizures in adults with epilepsy (ZONEGRAN used as add-on therapy to other antiepileptic drugs). [1]
Indications Not Approved on the U.S. Label
- Use in pediatric patients has not been established, and pediatric approval is not provided on the U.S. prescribing information. [1]
Clarification on Medication Name
- ZONEGRAN is a brand of zonisamide, not levetiracetam. [1]
Monotherapy vs Adjunctive Use
- ZONEGRAN is indicated for adjunctive use rather than monotherapy in the U.S. labeling. [1]